文献速递睡眠呼吸障碍小儿耳鼻咽喉咽喉与嗓音

阻塞性睡眠呼吸暂停儿童腺样体扁桃体切除术前后的吞咽困难结局:一项随机临床试验的二次分析

Dysphagia Outcomes Before and After Adenotonsillectomy in Children With Obstructive Sleep Apnea: A Secondary Analysis of a Randomized Clinical Trial.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2023-01-01

该研究为CHAT随机临床试验的二次分析,纳入386例5.0至9.9岁阻塞性睡眠呼吸暂停(OSA)患儿,随机分为腺样体扁桃体切除术(AT)组或观察等待加支持治疗(WWSC)组。结果显示AT组吞咽困难患病率下降21.3%(95%CI 13.5%-28.9%),WWSC组变化不显著(1.0%,95%CI -7.6%至9.6%),AT组吞咽困难缓解率高于WWSC组(调整OR 4.84,95%CI 1.91-12.25)。

要点

  • AT组吞咽困难患病率下降21.3%(95%CI 13.5%-28.9%),WWSC组变化不显著(1.0%,95%CI -7.6%至9.6%)。
  • AT组吞咽困难缓解可能性高于WWSC组(调整OR 4.84,95%CI 1.91-12.25)。
  • 基线AHI越高,吞咽困难缓解率越低(调整OR 0.91,95%CI 0.83-0.98)。

核心结论

  • 该CHAT随机临床试验二次分析提示,伴有吞咽困难的OSA患儿接受AT后吞咽困难可能改善。
  • 需要采用经验证的吞咽困难调查问卷的前瞻性随机试验来验证AT治疗吞咽困难的有效性。

研究设计与样本

  • 多中心随机临床试验(儿童腺样体扁桃体切除术试验,CHAT)的二次分析,2007年10月至2012年6月在三级儿童医院开展。
  • 共纳入386例5.0至9.9岁OSA患儿,随机分配至AT组或WWSC组,基线和7个月时行多导睡眠监测。
  • 照护者基线和7个月时完成OSA-18问卷,其中包含吞咽困难条目;本次二次分析于2022年12月1日至2023年1月10日进行。

主要发现

  • 基线时AT组吞咽困难56例(29.8%),WWSC组51例(25.8%),组间差异为4.0%(95%CI -4.9%至12.9%)。
  • AT组吞咽困难患病率下降21.3%(95%CI 13.5%-28.9%)。
  • WWSC组吞咽困难患病率变化不显著(1.0%,95%CI -7.6%至9.6%)。
  • AT组吞咽困难缓解可能性高于WWSC组(调整OR 4.84,95%CI 1.91-12.25)。
  • 基线AHI越高,吞咽困难缓解率越低(调整OR 0.91,95%CI 0.83-0.98)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Obstructive sleep apnea (OSA) and tonsil hypertrophy may be associated with dysphagia. However, randomized clinical trials assessing dysphagia outcomes in children randomized to adenotonsillectomy (AT) vs watchful waiting with supportive care (WWSC) are lacking. OBJECTIVE: To assess dysphagia outcomes in children with OSA and tonsil hypertrophy managed with AT or WWSC. DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis of a multicenter randomized clinical trial, the Childhood Adenotonsillectomy Trial (CHAT), was conducted at tertiary children's hospitals from October 2007 to June 2012. Children aged 5.0 to 9.9 years with OSA were randomized to AT or WWSC and underwent polysomnography at baseline and 7 months. Caregivers completed the OSA-18 questionnaire, which includes an item on difficulty in swallowing at baseline and 7 months. The current secondary analysis was conducted from December 1, 2022, to January 10, 2023. INTERVENTIONS: AT vs WWSC. MAIN OUTCOMES AND MEASURES: Prevalence of dysphagia, based on parental responses to the difficulty in swallowing item on the OSA-18 questionnaire, was redefined as a binary outcome at baseline and 7-month follow-up. RESULTS: In total, 386 children were included (199 female [51.6%]; median [IQR] age, 6.0 [5.0-8.0] years). Of the total, 207 children were Black (53.6%). At baseline, the number of children with dysphagia was similar (4.0%; 95% CI, -4.9% to 12.9%) between the AT group (56 [29.8%]) and the WWSC group (51 [25.8%]). Following AT, a decrease was observed (21.3%; 95% CI, 13.5%-28.9%) in the prevalence of dysphagia among the children. In contrast, the prevalence of dysphagia did not change significantly (1.0%; 95% CI, -7.6% to 9.6%) in the WWSC group. Children in the AT group were more likely to experience a resolution of dysphagia than those in the WWSC group (adjusted odds ratio, 4.84; 95% CI, 1.91-12.25). Higher baseline AHI was associated with a lower resolution of dysphagia (AOR, 0.91; 95% CI, 0.83-0.98). CONCLUSIONS AND RELEVANCE: This secondary analysis of the CHAT randomized clinical trial suggested that children with dysphagia and OSA undergoing AT may experience dysphagia improvement. A prospective randomized trial that uses a validated dysphagia survey is needed to verify the effectiveness of AT in treating dysphagia. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00560859.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Wang C, Hu H, Sun K, et al. Dysphagia Outcomes Before and After Adenotonsillectomy in Children With Obstructive Sleep Apnea: A Secondary Analysis of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 37590002. doi:10.1001/jamaoto.2023.2145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。